Terlipressin or Europressin?

Critical Care

Volumn 13, Issue 5, 2009, Pages

  Leone, Marc ^a  

^a HÔPITAL NORD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NORADRENALIN; TERLIPRESSIN; DRUG DERIVATIVE; LYPRESSIN; VASOCONSTRICTOR AGENT;

CONTINUOUS INFUSION; HUMAN; NONHUMAN; NOTE; PATIENT MONITORING; PRACTICE GUIDELINE; PRIORITY JOURNAL; SEPTIC SHOCK; VASOCONSTRICTION; VENOUS OXYGEN TENSION;

HUMANS; LYPRESSIN; SHOCK, SEPTIC; VASOCONSTRICTOR AGENTS;

EID: 77949905618     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc8035     Document Type: Note

References (14)

1. Morelli A, Ertmer C, Rehberg S, Lange M, Orecchioni A, Cecchini V, Bachetoni A, D'Alessandro M, Van Aken H, Pietropaoli P, Westphal M. Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study. Crit Care 2009, 13:R130. 2750187, 19664253, 10.1186/cc7990.
2. Scharte M, Meyer J, Van Aken H, Bone HG. Hemodynamic effects of terlipressin (a synthetic analog of vasopressin) in healthy and endotoxemic sheep. Crit Care Med 2001, 29:1756-1760. 10.1097/00003246-200109000-00017, 11546979.
3. O'Brien A, Clapp L, Singer M. Terlipressin for norepinephrine-resistant septic shock. Lancet 2002, 359:1209-1210. 10.1016/S0140-6736(02)08225-9, 11955542.
4. Leone M, Albanèse J, Delmas A, Chaabane W, Garnier F, Martin C. Terlipressin in catecholamine-resistant septic shock patients. Shock 2004, 22:314-319. 10.1097/01.shk.0000136097.42048.bd, 15377885.
5. Rodríguez-Núñez A, Fernández-Sanmartín M, Martinón-Torres F, González-Alonso N, Martinón-Sánchez JM. Terlipressin for catecholamine-resistant septic shock in children. Intensive Care Med 2004, 30:477-480. 10.1007/s00134-003-2114-3, 14767584.
6. Morelli A, Rocco M, Conti G, Orecchioni A, De Gaetano A, Cortese G, Coluzzi F, Vernaglione E, Pelaia P, Pietropaoli P. Effects of terlipressin on systemic and regional haemodynamics in catecholamine-treated hyperkinetic septic shock. Intensive Care Med 2004, 30:597-604. 10.1007/s00134-004-2244-2, 14673520.
7. Delmas A, Leone M, Rousseau S, Albanèse J, Martin C. Clinical review: vasopressin and terlipressin in septic shock patients. Crit Care 2005, 9:212-222. 1175907, 15774080, 10.1186/cc2945.
8. Bernadich C, Bandi JC, Melin P, Bosch J. Effects of F-180, a new selective vasoconstrictor peptide, compared with terlipressin and vasopressin on systemic and splanchnic hemodynamics in a rat model of portal hypertension. Hepatology 1998, 27:351-356. 10.1002/hep.510270206, 9462630.
9. Ryckwaert F, Virsolvy A, Fort A, Murat B, Richard S, Guillon G, Colson PH. Terlipressin, a provasopressin drug exhibits direct vasoconstrictor properties: consequences on heart perfusion and performance. Crit Care Med 2009, 37:876-881. 10.1097/CCM.0b013e31819b8199, 19237891.
10. Lange M, Morelli A, Ertmer C, Koehler G, Bröking K, Hucklenbruch C, Bone HG, Van Aken H, Traber DL, Westphal M. Continuous versus bolus infusion of terlipressin in ovine endotoxemia. Shock 2007, 28:623-629. 10.1097/shk.0b013e318050c836, 17589382.
11. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 2008, 34:17-60. 2249616, 18058085, 10.1007/s00134-007-0934-2.
12. Asfar P, Hauser B, Iványi Z, Ehrmann U, Kick J, Albicini M, Vogt J, Wachter U, Brückner UB, Radermacher P, Bracht H. Low-dose terlipressin during long-term hyperdynamic porcine endotoxemia: effects on hepatosplanchnic perfusion, oxygen exchange, and metabolism. Crit Care Med 2005, 33:373-380. 10.1097/01.CCM.0000152253.45901.FB, 15699842.
13. Russell JA, Walley KR, Singer J, Gordon AC, Hébert PC, Cooper DJ, Holmes CL, Mehta S, Granton JT, Storms MM, Cook DJ, Presneill JJ, Ayers D, VASST I. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008, 358:877-887. 10.1056/NEJMoa067373, 18305265.
14. Leone M, Boyle WA. Decreased vasopressin responsiveness in vasodilatory septic shock-like conditions. Crit Care Med 2006, 34:1126-1130. 10.1097/01.CCM.0000206466.56669.BE, 16484914.